In 2017, the multiple drug resistant rifampicin resistant regimen saw a 48 percent success rate. The death rate and lost to follow up stood at 19 and 18 percent respectively, while the failure rate of the drug was two percent during the same time period.
Share of TB treatment outcomes of MDR RR conventional regimen in India from 2007 to 2017
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Tuberculosis in India
Overview
3
Notifications
6
- Premium Statistic TB notifications India 2017-2022
- Premium Statistic Pediatric TB patients notified India 2022, by state
- Premium Statistic TB notification rate at time of diagnosis India 2022, by state
- Premium Statistic TB notifications India 2022, by state
- Premium Statistic Pediatric TB patients notified by private sector India 2022, by state
- Premium Statistic Pediatric TB patients notified in public sector India 2022, by state
Co-morbidities
3
Finance
3
Prevention
4
Treatment outcome
5
- Premium Statistic Share of TB patients on treatment versus short MDR TB treatment India 2018-2020
- Premium Statistic Share of TB patients India 2018, by regimen type
- Premium Statistic Share of TB treatment outcomes of MDR RR conventional regimen India 2007-2017
- Premium Statistic Share of TB treatment outcomes of XDR TB conventional regimen India 2012-2017
- Premium Statistic Number of tablets issued per adult TB patient India 2019, by weight band and phase
Outlook - predicted values until 2023
4
- Premium Statistic Number of notifications for TB elimination program India 2017-2023, by sector
- Premium Statistic Number of prescriptions for TB elimination program India 2018-2023, by sector
- Premium Statistic Number of tests for TB elimination program India 2018-2023, by sector
- Premium Statistic Number of presumptive cases for national TB elimination program India 2017-2023
Further related statistics
17
- Tuberculosis mortality rate globally as of 2017, by region
- Tuberculosis deaths globally in 2017, by region
- Number of deaths from tuberculosis Bangladesh 2008-2017
- Number of deaths from tuberculosis in Vietnam 2005-2021
- Number of tuberculosis cases in China 2015-2021
- Number of tuberculosis infections in Finland 1995-2022
- Number of deaths from tuberculosis Cambodia 2008-2017
- Number of deaths from tuberculosis in Indonesia 2008-2017
- Number of deaths from tuberculosis in Malaysia 2005-2017
- Funding for global TB by the U.S. 2001-2020
- Tuberculosis cases in South Korea 2012-2022
- New tuberculosis cases and relapses in Kosovo 2012-2022
- Projected number of people with tuberculosis Indonesia 2017-2024
- Deaths due to tuberculosis in Spain 2005-2022
- Industry revenue of “window treatment stores“ in California 2012-2024
- Gout therapeutics total market value U.S. 2015-2025
- Number and share waiting over 52 weeks for elective treatment in England 2007-2023
Further Content: You might find this interesting as well
Statistics
- Tuberculosis mortality rate globally as of 2017, by region
- Tuberculosis deaths globally in 2017, by region
- Number of deaths from tuberculosis Bangladesh 2008-2017
- Number of deaths from tuberculosis in Vietnam 2005-2021
- Number of tuberculosis cases in China 2015-2021
- Number of tuberculosis infections in Finland 1995-2022
- Number of deaths from tuberculosis Cambodia 2008-2017
- Number of deaths from tuberculosis in Indonesia 2008-2017
- Number of deaths from tuberculosis in Malaysia 2005-2017
- Funding for global TB by the U.S. 2001-2020
- Tuberculosis cases in South Korea 2012-2022
- New tuberculosis cases and relapses in Kosovo 2012-2022
- Projected number of people with tuberculosis Indonesia 2017-2024
- Deaths due to tuberculosis in Spain 2005-2022
- Industry revenue of “window treatment stores“ in California 2012-2024
- Gout therapeutics total market value U.S. 2015-2025
- Number and share waiting over 52 weeks for elective treatment in England 2007-2023
Ministry of Health and Family Welfare (India). (June 24, 2020). Share of TB treatment outcomes of MDR RR conventional regimen in India from 2007 to 2017 [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/1188630/india-share-of-tb-treatment-outcomes-of-mdr-rr-conventional-regimen/
Ministry of Health and Family Welfare (India). "Share of TB treatment outcomes of MDR RR conventional regimen in India from 2007 to 2017." Chart. June 24, 2020. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/1188630/india-share-of-tb-treatment-outcomes-of-mdr-rr-conventional-regimen/
Ministry of Health and Family Welfare (India). (2020). Share of TB treatment outcomes of MDR RR conventional regimen in India from 2007 to 2017. Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/1188630/india-share-of-tb-treatment-outcomes-of-mdr-rr-conventional-regimen/
Ministry of Health and Family Welfare (India). "Share of Tb Treatment Outcomes of Mdr Rr Conventional Regimen in India from 2007 to 2017." Statista, Statista Inc., 24 Jun 2020, https://www.statista.com/statistics/1188630/india-share-of-tb-treatment-outcomes-of-mdr-rr-conventional-regimen/
Ministry of Health and Family Welfare (India), Share of TB treatment outcomes of MDR RR conventional regimen in India from 2007 to 2017 Statista, https://www.statista.com/statistics/1188630/india-share-of-tb-treatment-outcomes-of-mdr-rr-conventional-regimen/ (last visited May 13, 2024)
Share of TB treatment outcomes of MDR RR conventional regimen in India from 2007 to 2017 [Graph], Ministry of Health and Family Welfare (India), June 24, 2020. [Online]. Available: https://www.statista.com/statistics/1188630/india-share-of-tb-treatment-outcomes-of-mdr-rr-conventional-regimen/